Search

everythinglearnresearchcommunity

for

Search:↓

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.

34% of patients on hepatitis C treatment had reversible skin issues.

A man with syphilitic alopecia and neurosyphilis was successfully treated with penicillin, leading to symptom improvement and resolution of hair loss.

PCOS affects about 6.3% of teens globally, and ongoing checks are advised for those with irregular cycles or high androgen levels.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

The study found that the quality of cord blood units remains consistent before freezing and after thawing, indicating that attached tube segments reliably represent the graft's properties.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

A heart transplant patient developed a skin condition called epidermodysplasia verruciformis after taking immune-suppressing drugs.

The model and estimator can predict drug exposure in kidney transplant patients well.

Antiviral medication valganciclovir may improve skin and hair in Trichodysplasia Spinulosa patients.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

Most children with MIS-C showed significant improvement by 6 months.

Research on HIV-1 capsid inhibitors has progressed significantly, with the U.S. leading in contributions.

Combining TUSV with finasteride effectively treats recurrent hemospermia.

Pediatric transplant patients often experience unique skin changes mainly due to medication use.

A 5-year-old boy's skin condition improved with systemic valganciclovir after a cardiac transplant and immunosuppressive therapy.

A stray cat with severe scabies recovered after 4 weeks of treatment.

Experts recommend a team-based approach to treat patients with long-lasting COVID-19 symptoms and emphasize the need for ongoing research.

Long COVID affects over half of COVID-19 survivors, causing a range of symptoms like fatigue and neurological issues, with no specific treatment yet.

Completing a 14-day proxalutamide treatment significantly lowers death rates in hospitalized COVID-19 patients.

Many transgender men on testosterone therapy experience hair loss.

Greater intimacy leads to better self-reported health in couples having infertility treatment.

Anti-androgen therapy may boost immunity but increases injection site pain in vaccinated patients.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

A new skin cancer can develop where shingles once occurred.

ICL is a condition with low CD4+ T cells like AIDS but not caused by HIV, and normal CD4+ T cell counts may vary between men and women.

The transscrotal testosterone patch normalizes hormone levels in men with AIDS and weight loss but does not improve weight, body mass, or quality of life.

Post-COVID, many patients experience skin issues like hair loss and herpes reactivation, especially in middle-aged women.

The study suggests a link between varicella-zoster virus and segmental vitiligo, with evidence of the virus disrupting skin pigment cells.